Related Experiment Video
Updated: Jun 20, 2026

A Porcine Heterotopic Heart Transplantation Protocol for Delivery of Therapeutics to a Cardiac Allograft
Published on: February 14, 2022
Revolutionizing Donor Heart Procurement: Innovations and Future Directions for Enhanced Transplantation Outcomes
1Department of Cardiothoracic Surgery, Stanford University School of Medicine, 300 Pasteur Drive, Falk CVRB, Stanford, CA 94305, USA.
Insights
Innovations in donor heart procurement, including machine perfusion and expanded donor criteria, are increasing organ availability for heart transplantation. These advancements aim to improve outcomes for patients with end-stage heart failure.
Area of Science:
- Cardiology
- Transplantation Medicine
- Surgical Innovation
Background:
- Heart failure remains a significant public health issue, with heart transplantation being the primary treatment for end-stage cases.
- Limited donor heart availability is a major barrier to successful transplantation, impacting patient access to life-saving treatment.
Purpose of the Study:
- To review recent advancements in donor heart procurement and preservation techniques.
- To explore strategies for expanding the donor pool and optimizing donor heart utilization.
- To discuss future directions in heart transplantation, including xenotransplantation and artificial intelligence.
Main Methods:
- Review of literature on donor heart procurement, recovery, evaluation, and preservation.
- Analysis of innovative technologies such as normothermic machine perfusion and hypothermic oxygenated perfusion.
- Examination of extended-criteria, post-cardiopulmonary resuscitation, and high-risk donor utilization.
Main Results:
- Significant progress in donor heart procurement has expanded the donor pool and improved clinical outcomes.
- Innovative techniques like normothermic machine perfusion and novel preservation methods enhance organ viability.
- Utilizing extended-criteria and high-risk donors increases availability without compromising patient outcomes.
Conclusions:
- Recent advancements in donor heart procurement and preservation are crucial for addressing donor shortages.
- Innovative technologies and expanded donor criteria offer promising solutions to improve heart transplantation success.
- Future research in xenotransplantation, biomarkers, and AI holds potential for further optimizing donor heart utilization and patient outcomes.
Abstract:
Heart failure persists as a critical public health challenge, with heart transplantation esteemed as the optimal treatment for patients with end-stage heart failure. However, the limited availability of donor hearts presents a major obstacle to meeting patient needs. In recent years, the most groundbreaking progress in heart transplantation has been in donor heart procurement, significantly expanding the donor pool and enhancing clinical outcomes. This review comprehensively examines these advancements, including the resurgence of heart donation after circulatory death and innovative recovery and evaluation technologies such as normothermic machine perfusion and thoraco-abdominal normothermic regional perfusion. Additionally, novel preservation methods, including controlled hypothermic preservation and hypothermic oxygenated perfusion, are evaluated. The review also explores the use of extended-criteria donors, post-cardiopulmonary resuscitation donors, and high-risk donors, all contributing to increased donor availability without compromising outcomes. Future directions, such as xenotransplantation, biomarkers, and artificial intelligence in donor heart evaluation and procurement, are discussed. These innovations promise to address current limitations and optimize donor heart utilization, ultimately enhancing transplantation success. By identifying recent advancements and proposing future research directions, this review aims to provide insights into advancing heart transplantation and improving patient outcomes.
Related Concept Videos
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Kidney Transplant I: Introduction

